Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
UC

NYSE · UCB

United Community Banks, Inc.

Financial Services · Banks - Regional

$36.73

Down-$0.48 (-1.29%)

Updated Nov 2, 2026, 6:13 AM

SID Score

7.0/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.94B
P/E ratio
12.47
Dividend yield
3.32%
52-week range
$28.65 – $37.45
Volume
1.05M
Avg. volume
661.41K

Price performance · UCB

UCB price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

UCB closed at $36.73 after 20 trading sessions, up 8.64% for the selected period.

Last close
$36.73
Period change
+8.64%
Period low
$33.16
Period high
$37.23
Daily close
View OHLC price history
UCB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$37.43$37.44$36.53$36.731.05M
Oct 29, 2026$37.10$37.36$36.93$37.211.12M
Oct 28, 2026$36.70$36.76$36.12$36.561.18M
Oct 27, 2026$37.24$37.24$36.464$36.75722.85K
Oct 26, 2026$37.23$37.45$36.915$37.121.25M
Oct 23, 2026$37.07$37.335$36.41$36.991.57M
Oct 22, 2026$35.65$37.24$35.65$37.231.76M
Oct 21, 2026$35.78$35.92$35.41$35.851.89M
Oct 20, 2026$34.00$35.505$33.78$35.471.63M
Oct 19, 2026$33.96$34.09$33.76$33.78779.6K
Oct 16, 2026$34.23$34.61$33.83$34.09911.92K
Oct 15, 2026$33.50$34.06$33.27$34.051.13M
Oct 14, 2026$32.80$33.31$32.72$33.161.2M
Oct 13, 2026$33.74$33.85$33.16$33.371.06M
Oct 12, 2026$33.29$33.785$33.29$33.58785.92K
Oct 9, 2026$33.47$33.575$33.16$33.38627.02K
Oct 8, 2026$33.06$33.625$32.97$33.581.07M
Oct 7, 2026$33.34$33.46$32.985$33.26994.74K
Oct 6, 2026$33.97$34.15$33.635$33.72996.18K
Oct 5, 2026$34.16$34.2057$33.66$33.81990.5K

Latest UCB news

The latest Smart Investors Daily articles mentioning UCB.

Stock researchCompany · Overview

UCB research

Overview

Company profile and research snapshot.

Company profile

United Community Banks Inc provides a wide range of financial products and services to the commercial, retail, governmental, educational, energy, health care and real estate sectors. This includes a variety of deposit products, secured and unsecured loans, mortgage loans, payment and commerce solutions, equipment finance services, wealth management, trust services, private banking, investment advisory services, insurance services, and other related financial services. These products and services are delivered through a variety of channels including its branches, other offices, the Internet, and mobile applications. It operates as a locally-focused community bank, supplemented by experienced, centralized support to deliver products and services to its larger, more sophisticated, customers.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$32.00
Implied upside
—
Analysts
—
UCB recent ratings
DateFirmRatingTarget
Oct 21, 2026Stephens & Co.Overweight—
Sep 16, 2026Keefe, Bruyette & WoodsOutperform—
Sep 9, 2026Piper SandlerNeutral—
Sep 9, 2026DA DavidsonBuy—
Jul 22, 2026DA DavidsonBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

Higher Rates Still Matter for U.S. Bank Stocks Like Pinnacle Financial Partners

Fed officials just reminded investors that 2% inflation really means 2% flat, and that keeps rate pressure alive even with no move today. Elevated short-term yields can reshape where money flows, reward some business models and strain others. This article unpacks that tension and walks through three U.S. financial stocks exposed to this rate story so you can decide whether they belong on your watchlist. The three stocks below are just a starting sample, and the full screen surfaced 37 more...

Yahoo · Oct 23, 2026

UCB Establishes the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and Women's Hospital

UCB, a global biopharmaceutical company focused on severe diseases, today announced the establishment of the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and Women's Hospital, a founding member of the Mass General Brigham system. Named in honor of Emmanuel Janssen and his legacy at UCB, the chair recognizes a longstanding commitment to advancing science and improving patient care. Sebastian Schneeweiss, MD, ScD, has been named the chair's inaugural incumbent.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By